Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowLiver TransplantationBone Marrow CellsKidney TransplantationHematologic NeoplasmsTreatment OutcomeTransplantation ChimeraWhole-Body IrradiationRetrospective StudiesPeripheral Blood Stem Cell TransplantationStem CellsLiving DonorsTissue DonorsGraft SurvivalLeukemiaBusulfanHistocompatibility TestingTissue and Organ ProcurementHistocompatibilityHematopoiesisAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationCombined Modality TherapyImmunosuppressive AgentsRemission InductionHematopoietic Stem Cell MobilizationCyclophosphamideGraft vs Leukemia EffectTransplantation, IsogeneicAntigens, CD34Leukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseMyeloablative AgonistsTime FactorsBone and BonesMice, Inbred C57BLChimerismCell DifferentiationHematologic DiseasesHLA AntigensTransplantation ImmunologyMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisSevere Combined ImmunodeficiencyBone Marrow PurgingMultiple MyelomaSurvival RateGraft RejectionGraft vs Tumor EffectLymphocyte TransfusionColony-Forming Units AssayCell TransplantationDisease-Free SurvivalMesenchymal Stem Cell TransplantationLymphocyte DepletionFlow CytometryMelphalanAcute DiseaseImmunosuppressionT-LymphocytesCell LineageLymphoma, Non-HodgkinBone Marrow DiseasesLeukemia, MyeloidHeart TransplantationGranulocyte Colony-Stimulating FactorCytomegalovirus InfectionsSiblingsRadiation ChimeraAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesVidarabineUnrelated DonorsAntilymphocyte SerumLung TransplantationOrgan TransplantationCells, CulturedSalvage TherapyFetal BloodStem Cell NicheCyclosporineCell SeparationCytarabineOpportunistic InfectionsPrognosisEmbryonic Stem CellsAdult Stem CellsTransplantationLeukocyte Transfusion